TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)
Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the efficacy of Telitacicept in the treatment of inflammatory myopathy in patients with inflammatory diseases. The main question it aims to answer is: the safety and effectiveness of Telitacicept in treating inflammatory myopathy.